Published in Kidney Blood Press Res on September 19, 2014
Cardiac actions of fibroblast growth factor 23. Bone (2016) 0.75
Liver fibrosis. J Clin Invest (2005) 17.27
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet (2010) 7.69
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med (2008) 7.21
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41
Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med (2006) 6.25
Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol (1998) 4.67
Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int (2006) 3.63
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension (2008) 2.99
Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int (2007) 2.15
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. J Am Soc Nephrol (2011) 2.07
Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol (2006) 2.04
1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol (2003) 1.86
Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol (2007) 1.66
Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 1.64
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int (2008) 1.36
The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci (2003) 1.34
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol (2001) 1.30
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int (2001) 1.17
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation (2010) 1.08
Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. Am J Physiol Renal Physiol (2011) 1.08
Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia (2010) 1.08
Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens (1992) 1.01
Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol (2008) 1.00
Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am J Physiol Endocrinol Metab (2006) 1.00
Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. Am J Physiol Renal Physiol (2011) 0.98
Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol (2013) 0.92
Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol (2010) 0.92
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD. J Am Soc Nephrol (2012) 0.91
Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats. Kidney Blood Press Res (2012) 0.88
Endothelin in chronic proteinuric kidney disease. Contrib Nephrol (2011) 0.82
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats. Br J Pharmacol (2007) 0.82
Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis. Nephrol Dial Transplant (2013) 0.81
Novel markers of left ventricular hypertrophy in uremia. Am J Nephrol (2010) 0.80
Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Br J Pharmacol (2006) 0.79
Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. Eur J Pharmacol (2014) 0.78
Vitamin D. Am J Physiol Renal Physiol (2005) 4.81
Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol (2009) 2.29
Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int (2005) 2.24
Apparent elastic modulus and hysteresis of skeletal muscle cells throughout differentiation. Am J Physiol Cell Physiol (2002) 2.18
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16
Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int (2005) 2.15
Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol (2013) 2.09
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest (2012) 1.91
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol (2010) 1.78
Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol (2012) 1.73
Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasome. J Am Soc Nephrol (2012) 1.72
Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol (2007) 1.66
The effects of angiotensin-converting-enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg (2007) 1.41
Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol (2002) 1.36
Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int (2003) 1.29
Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol (2010) 1.27
Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med (2008) 1.20
Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int (2004) 1.18
Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J (2003) 1.17
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol (2005) 1.16
Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest (2008) 1.15
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab (2007) 1.14
Normalization of glucose post-transplantation of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35. Transpl Immunol (2005) 1.14
Glomerulocystic kidney: one hundred-year perspective. Arch Pathol Lab Med (2010) 1.14
Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity. Mol Cell Biol (2008) 1.12
Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport. J Lab Clin Med (2002) 1.11
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int (2003) 1.11
1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem (2002) 1.10
Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol (2008) 1.10
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol (2002) 1.10
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol (2009) 1.10
Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats. Transpl Immunol (2006) 1.09
Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. Am J Physiol Renal Physiol (2011) 1.08
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.07
Morphologic heterogeneity of renal light-chain deposition disease. Ultrastruct Pathol (2008) 1.03
Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol (2008) 1.00
Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol (2005) 0.98
EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol (2008) 0.97
Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas. Am J Nephrol (2010) 0.97
Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp Gerontol (2011) 0.96
Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab (2005) 0.96
Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury. J Pathol (2012) 0.95
Intraperitoneal transplantation of pancreatic anlagen. ASAIO J (2003) 0.95
Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant (2002) 0.94
A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol (2005) 0.94
Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats. Am J Pathol (2010) 0.93
Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant (2007) 0.93
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients. Am J Kidney Dis (2002) 0.93
The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol (2013) 0.92
Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol (2010) 0.92
Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats. Kidney Int (2002) 0.92
Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol (2005) 0.92
Reduced Notch signaling leads to renal cysts and papillary microadenomas. J Am Soc Nephrol (2010) 0.91
Selective versus nonselective arterial clamping during laparoscopic partial nephrectomy: impact upon renal function in the setting of a solitary kidney in a porcine model. J Endourol (2009) 0.91
Podocyte loss involves MDM2-driven mitotic catastrophe. J Pathol (2013) 0.91
Expression profiles of congenital renal dysplasia reveal new insights into renal development and disease. Pediatr Nephrol (2007) 0.90
Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching. J Am Soc Nephrol (2003) 0.90
Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. Am J Cardiol (2008) 0.89
Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations. Hum Genet (2012) 0.89
Importance of vitamin D and vitamin D levels status in Puerto Ricans. J Health Care Poor Underserved (2013) 0.88
FGF23 and PTH--double agents at the heart of CKD. Nephrol Dial Transplant (2012) 0.88
Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients. Am J Surg Pathol (2007) 0.88
Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Invest (2010) 0.88
Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification. Kidney Int (2013) 0.86
Diagnostic dilemmas in atypical postinfectious glomerulonephritis. Semin Diagn Pathol (2002) 0.86
Destabilization of parathyroid hormone mRNA by extracellular Ca2+ and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription. J Mol Endocrinol (2008) 0.86
Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. Am J Kidney Dis (2002) 0.86
Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum Exp Toxicol (2010) 0.86
Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria. PLoS One (2013) 0.86
Vitamin D receptor and analogs. Semin Nephrol (2004) 0.86
Engraftment of cells from porcine islets of Langerhans following transplantation of pig pancreatic primordia in non-immunosuppressed diabetic rhesus macaques. Organogenesis (2011) 0.86
Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivo. Physiol Genomics (2006) 0.85
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Am J Kidney Dis (2009) 0.85
High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis. J Biol Chem (2008) 0.85
Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults. Nefrologia (2013) 0.85
Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Am J Nephrol (2009) 0.84
An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis. Regul Pept (2007) 0.84
Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism. J Am Soc Nephrol (2008) 0.83
Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. Am J Nephrol (2011) 0.83
Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res (2009) 0.83
Red cell traverse through thin glomerular basement membrane. Kidney Int (2002) 0.83
Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. Nephrol Dial Transplant (2002) 0.82
Ablation of developing podocytes disrupts cellular interactions and nephrogenesis both inside and outside the glomerulus. Am J Physiol Renal Physiol (2008) 0.82
Microvessel formation from mouse embryonic aortic explants is oxygen and VEGF dependent. Am J Physiol Regul Integr Comp Physiol (2002) 0.82
Novel markers of left ventricular hypertrophy in uremia. Am J Nephrol (2010) 0.80